Engineered skin bacteria induce antitumor T cell responses against melanoma

成果类型:
Article
署名作者:
Chen, Y. Erin; Bousbaine, Djenet; Veinbachs, Alessandra; Atabakhsh, Katayoon; Dimas, Alex; Yu, Victor K.; Zhao, Aishan; Enright, Nora J.; Nagashima, Kazuki; Belkaid, Yasmine; Fischbach, Michael A.
署名单位:
Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Chan Zuckerberg Initiative (CZI)
刊物名称:
SCIENCE
ISSN/ISSBN:
0036-10074
DOI:
10.1126/science.abp9563
发表日期:
2023-04-13
页码:
203-210
关键词:
immune-responses immunotherapy exhaustion expression tolerance resident
摘要:
Certain bacterial colonists induce a highly specific T cell response. A hallmark of this encounter is that adaptive immunity develops preemptively, in the absence of an infection. However, the functional properties of colonist-induced T cells are not well defined, limiting our ability to understand anticommensal immunity and harness it therapeutically. We addressed both challenges by engineering the skin bacterium Staphylococcus epidermidis to express tumor antigens anchored to secreted or cell-surface proteins. Upon colonization, engineered S. epidermidis elicits tumor-specific T cells that circulate, infiltrate local and metastatic lesions, and exert cytotoxic activity. Thus, the immune response to a skin colonist can promote cellular immunity at a distal site and can be redirected against a target of therapeutic interest by expressing a target-derived antigen in a commensal.